-+ 0.00%
-+ 0.00%
-+ 0.00%

Voyageur Pharmaceuticals proposes converting $192,300 debt into shares at $0.155 each

PUBT·09/24/2026 21:55:16
Voyageur Pharmaceuticals proposes converting $192,300 debt into shares at $0.155 each
  • Voyageur Pharmaceuticals proposed converting $192,300 of debt into common shares to conserve cash.
  • Settlement priced at $0.155 per share, implying issuance of 1,240,644 common shares.
  • $52,300 owed to an officer to be settled with 337,419 shares.
  • $140,000 owed to other creditors to be settled with 903,225 shares.
  • Closing subject to regulatory sign-off, including TSX Venture Exchange final acceptance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyageur Pharmaceuticals Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202609241752NEWSFILECNPR____20260924_315987_1) on September 24, 2026, and is solely responsible for the information contained therein.